Becton, Dickinson and Co. (BDX) is a publicly traded Healthcare sector company. As of May 20, 2026, BDX trades at $147.16 with a market cap of $39.22B and a P/E ratio of 37.18. BDX moved +0.07% today. Year to date, BDX is -24.62%; over the trailing twelve months it is -17.00%. Its 52-week range spans $141.82 to $251.99. Analyst consensus is buy with an average price target of $182.20. Rallies surfaces BDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
BDX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BDX recently traded at $147.16. Market cap is $39.22B. P/E ratio is 37.18. Revenue is $21.37B.
| Metric | Value |
|---|---|
| Price | $147.16 |
| Market Cap | $39.22B |
| P/E Ratio | 37.18 |
| EPS | $3.95 |
| Dividend Yield | 1.05% |
| 52-Week High | $251.99 |
| 52-Week Low | $141.82 |
| Volume | 2.06M |
| Avg Volume | 0 |
| Revenue (TTM) | $21.37B |
| Net Income | $1.14B |
| Gross Margin | 46.79% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $21.84B | $1.68B | $5.83 |
| 2023 | $19.37B | $1.48B | $4.97 |
| 2022 | $18.87B | $1.78B | $5.93 |
| 2021 | $20.25B | $2.09B | $6.92 |
10 analysts cover BDX: 0 strong buy, 5 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $182.20.